Cancer Research Cancer Genome no Abstract
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, C.
Right arrow Articles by Kalluri, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, C.
Right arrow Articles by Kalluri, R.
[Cancer Research 63, 8312-8317, December 1, 2003]
© 2003 American Association for Cancer Research


Regular Articles

Integrin {alpha}1ß1 and {alpha}2ß1 Are the Key Regulators of Hepatocarcinoma Cell Invasion Across the Fibrotic Matrix Microenvironment

Changqing Yang, Michael Zeisberg, Julie C. Lively, Pia Nyberg, Nezam Afdhal and Raghu Kalluri

Center for Matrix Biology, Division of Gastroenterology, Department of Medicine and The Liver Center, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts

As with many types of cancer, cell motility is an important factor in the progression and metastasis of hepatocellular carcinomas (HCC). HCC is associated with significant fibrosis in the liver. The fibrotic microenvironment in the liver is characterized by an altered composition of the extracellular matrix (ECM) and an abundance of growth factors that are likely conducive to migration of HCC cells. The purpose of this study was to delineate promigratory stimuli within the fibrotic microenvironment and to identify specific targets for prevention of HCC cell migration. We used a modified Boyden chamber system that allowed distinction between chemotactic (indirect stimulation) and haptotactic (direct stimulation) migration of two distinct HCC cell lines across the ECM-coated membrane. Fibrotic microenvironment-associated growth factors, such as transforming growth factor ß1 (TGF-ß1), basic fibroblast growth factor (bFGF), and epidermal growth factor (EGF), induced chemotactic and haptotactic migration of HepG2 and Chang cells. Neutralizing antibodies to individual growth factors significantly decreased chemotactic and haptotactic migration. Haptotactic stimulation, but not chemotactic stimulation of HCC cell lines with TGF-ß1, bFGF, and EGF, induced production of matrix metalloproteinase (MMP) 2, a potential mediator of migration. Inhibition of MMPs significantly decreased haptotactic migration induced by individual growth factors but had an insignificant effect on chemotactic migration, suggesting an MMP-independent migration in this setting. Inhibition of cell-ECM interactions with blocking antibodies to {alpha}1 and {alpha}2 integrins were sufficient to inhibit both haptotactic and chemotactic migration induced by individual growth factors, strongly suggesting that targeting these integrins to abrogate pathogenic cell-ECM interactions might be a promising tool for inhibiting growth factor-induced invasion and metastasis of HCC.




This article has been cited by other articles:


Home page
IOVSHome page
Y.-W. Peng, M. Zallocchi, D. T. Meehan, D. Delimont, B. Chang, N. Hawes, W. Wang, and D. Cosgrove
Progressive Morphological and Functional Defects in Retinas from {alpha}1 Integrin-Null Mice
Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4647 - 4654.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Richter, S. J. Ray, T. J. Chapman, S. J. Austin, J. Rebhahn, T. R. Mosmann, H. Gardner, V. Kotelianski, A. R. deFougerolles, and D. J. Topham
Collagen Distribution and Expression of Collagen-Binding {alpha}1beta1 (VLA-1) and {alpha}2beta1 (VLA-2) Integrins on CD4 and CD8 T Cells during Influenza Infection
J. Immunol., April 1, 2007; 178(7): 4506 - 4516.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
A. Sutton, V. Friand, S. Brule-Donneger, T. Chaigneau, M. Ziol, O. Sainte-Catherine, A. Poire, L. Saffar, M. Kraemer, J. Vassy, et al.
Stromal Cell-Derived Factor-1/Chemokine (C-X-C Motif) Ligand 12 Stimulates Human Hepatoma Cell Growth, Migration, and Invasion
Mol. Cancer Res., January 1, 2007; 5(1): 21 - 33.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. K. Wang, L. Hu, G. N. Fuller, and W. Zhang
An Interaction between Insulin-like Growth Factor-binding Protein 2 (IGFBP2) and Integrin {alpha}5 Is Essential for IGFBP2-induced Cell Mobility
J. Biol. Chem., May 19, 2006; 281(20): 14085 - 14091.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M.-R. Shen, Y.-M. Hsu, K.-F. Hsu, Y.-F. Chen, M.-J. Tang, and C.-Y. Chou
Insulin-like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by {alpha}v{beta}3 integrin signaling
Carcinogenesis, May 1, 2006; 27(5): 962 - 971.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. S. Sawhney, M. M. Cookson, B. Sharma, J. Hauser, and M. G. Brattain
Autocrine Transforming Growth Factor {alpha} Regulates Cell Adhesion by Multiple Signaling via Specific Phosphorylation Sites of p70S6 Kinase in Colon Cancer Cells
J. Biol. Chem., November 5, 2004; 279(45): 47379 - 47390.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.